ABSTRACT
Introduction
The objective of this article is to develop an inference method based on outcomes from mammary tumor studies containing different types of missing observations. We derive accurate likelihood functions and focus on the maximum likelihood comparison between populations that may have values below the limit of detection caused by low instrument sensitivity.
Specifically, the method proposed in this article is motivated by a gene deficiency study performed at Roswell Park Cancer Institute, Buffalo, NY, which investigated the longitudinal growth of breast cancer in mice. The mouse tumor model was used to study the relationship between the loss of the gene Thoc1 and mammary tumor growth progression (Wang, 2008) . In this mouse model, mammary hyperplasia can be detected as early as 4 weeks of age. In addition a large percentage of mice develop carcinoma by 14 weeks (KellySpratt et al., 2008). Female mice with three genotypes, namely Thoc1F/FPyMT+/-, Thoc1F/FMMTVCre+/-PyMT+/-and Thoc1F/+MMTVCre+/-PyMT+/-(control) were followed for 35 weeks (Wang, 2008) . The mice were palpated once weekly from 8 weeks of age to monitor mammary tumor development.
Breast tumors can be palpable when their diameters reach 0.5mm (Kuang et al., 2004) ; however, the tumor is often too small to be detected during certain periods (e.g., early stage) of its development (e.g., Tan et al., 2002) . This problem can be considered in terms of the limit of detection (henceforth, referred as LOD) due to instrument sensitivity (e.g., Schisterman, 2006; Perkins et al., 2007; Yu et al., 2009 ). Further, when primary tumors reach a certain size (approximately 2cm in diameter), mice are euthanized according to the study protocol, thus generating missing data. In general, a substantial proportion of data is missing as a function of time, leading to underestimated tumor growth rates. Another possible cause of missing data is a drop-out from natural death attributed to a treatment effect (e.g., toxicity, see Tan et al., 2002) . In this setting, the missing pattern itself has valuable information related to treatment response.
When portions of the data are below the LOD, existing literature commonly suggests a parametric approach (e.g., Lynn To handle missing data in longitudinal studies, parametric methods also have been actively developed (e.g., Rubin, 1977 Rubin, , 1987 Rosenbaum and Rubin, 1983; Little, 1988; Diggle and Kenward, 1994) . Hughes (1999) and Vaida et al. (2007) proposed an MCEM algorithm and hybrid EM algorithm (lmec package in R), respectively, to handle censored responses in the frame work of a linear mixedeffects model described in Laird and Ware (1982) .
For mouse tumor models, most statistical studies have focused on measuring the tumor. Koziol et al. (1981) proposed a nonparametric method based on multivariate rank statistics to compare mice tumor growth curves, but did not handle the critical LOD issue. Tan et al. (2002) considered this in the tumor xenograft model by assuming normal distribution based models proposing two alternative parametric approaches, one based on EM algorithm and the other on a Bayesian methodology. Missing values were considered as missing at random while the death rate was not of specific interest in their study. Liang and Sha (2004) used a non-linear mixed effect model to analyze the data from Tan et al. (2002) , where the observations were assumed to have normal distributions and the dropout pattern was considered as missing at random. The death rate was not taken into account in their analysis and the unavailable data caused by the LOD were simply imputed by a single value in their analysis. Albert and Shih (2003) modeled the relationship between clones of mouse cells with genetic mutations and tumor progression. Modeling tumor growth was suggested as an approach to overcome the bias problem caused by the missing data, where the drop-out mechanism was considered as missing at random. Mean tumor growth was defined as a function of the probability of the onset time in conjunction with a model of tumor growth after onset. The LOD was not of specific interest in their study.
In this article, we develop a test to compare K-groups utilizing the maximum likelihood ratio which is known to be locally most powerful taking into account the LOD and the drop-out mechanism jointly. Unlike other tumor studies with animals, for the mammary tumor experiments, the tumor is measurable throughout the study; however, the tumor measurement is often subject to the limit of detection due to insensitive tools as stated earlier. Besides, under a wellcontrolled study environment, the cause of drop-out is clear, thus often the dropout itself has information to be considered. We classify the causes of missing data into two categories, namely missing data due to euthanasia and missing data due to natural death (causes other than euthanasia). This distinction is important in that natural death provides extra information regarding treatment differences, while the decision of euthanasia directly depends on the size of the tumor. While we adapt the likelihood approach, in principle, we propose a method that is not limited by the normal distribution assumption but can work with a data set under more general distribution assumption (e.g., Bondon, 2009) , so that our method has its own unique generalizability (more details in Section 4). This article has the following structure. In Section 2 we first specify the observation patterns for successive assessments of tumor volume, and derive the parametric likelihood function based on incomplete longitudinal data. A likelihood ratio test for examining differences among K -groups is developed and its asymptotic properties are considered. In Section 3 the performance of the proposed method is evaluated using an extensive Monte-Carlo study. In Section 4 we apply the proposed method to analyze actual data sets from mouse tumor experiments. Section 5 is devoted to concluding remarks.
Main result

Model development
Consider a study with K treatment groups. For treatment group k ( 
there are k n experimental units. Each experimental unit is assumed to be examined at J equally spaced time points by a pre-specified schedule. 
where   One can remark that it is a very complicated problem to test for the correlation structure subject to the pattern of the missing data. In the context of the mammary tumor study, model (1) We note that higher order autoregression structures can be used by modifying (1) , where the autoregression coefficient  can be considered as a function of j, which will require substantial mathematical details and be subject to future study. Note that, using (1), the variables
where
, indicating more variability into the variance/covariance structure when the time goes on. This covariance also indicates that, when the time passes, the values of the variance are more stabilized as j increases, much alike the typical autoregressive covariance structure with normally distributed data (e.g., Diggle, 1988; Tan et al., 2002 ).
Suppose that a mouse i in group k is euthanized if its tumor size is greater than . The dot indicates a missing value due to death of a mouse. Cases 5 and 6 both indicate missing at time j by reasons other than euthanasia. Case 7 indicates that an animal is euthanized at time j. 
Defining the likelihood function
In this section, we limit our discussion within a single group (say, the k th group) for simplicity. In this case, the general form of the likelihood function is
where θ indicates the parameters to define model (1) , ,
where I is an indicator function that takes the value of 1 if the condition in the bracket is satisfied and 0 otherwise. According to the cases in Table 1 , (4) can be expressed as
where l E is the collection of   Consider the conditional probabilities in (5 
.
Similarly, for Cases 3 and 4, one can show that the probabilities of the measurement process ij X and ij A are separated. For Case 5,
Similarly, for Case 6,
Incorporating Formulas (6) and (7) into the likelihood function allows us to take into account the probabilities of natural deaths in hypothesis testing.
For Case 7, Table 1 . For Case 1,
For the numerator of (9), using (2), we have
Differentiating (10) 
since the denominator of (9) is  
whereas ij X is observed. Hence, we obtain
For Case 3 where
Note that, in a different context, a similar approach to these modifications of conditional probabilities is found in Park et al. (2007) , where items such as , if , and , if
Combining (6)- (8), and (11)- (15), we derive the likelihood function with respect to a sequence of measurements for each animal.
The test statistic
for Case 1 in Table 1 . Also, let  
be the conditional density for all groups; that is, 
where 
where   
Finally, given the formal notation at (17) and (18), we complete the likelihood ratio statistic,
to carry forth testing of hypothesis 0 H in (16).
Implementation to analyze the real data set
The estimation of j  for time j ( 1,..., j J  ) may be biased because of the LOD mechanism and the large portion of missing values due to euthanasia as a consequence of large tumor sizes. Modeling tumor growth dependent upon time j should be a reasonable alternative to the current approaches. In general, the growth of tumors can be approximated by polynomial forms. For example, (20) assuming that the mean as a function of time has a   . Note that if an anti-cancer treatment is effective (e.g., Section 3), higher order polynomials may be desirable since the tumor size often decreases before it increases again. We also consider that jk p is constant over time, that is, 1
. The reasons for this consideration are two-fold. First, the rate of natural death incurred by toxicity can assumed to be constant throughout the study period. Second, estimating a death rate for each time j may not be feasible with small sample sizes. The robustness of this approach for an assumption of changing rates is discussed in Section 4. Using this adaptation and the likelihood function (17), the maximum likelihood estimator of the death rate, p , under 0 H , is
The derivation of this estimator is easily carried out since the function of the measurement process and the function of the death rate in the likelihood (17) can be handled separately. Under 1 H , ˆk p is obtained for each group, k , in a similar manner to that shown above. By performing an appropriate transformation (e.g., Box-Cox power transformation), and assuming the tumor volumes to be normally distributed, the exact formulas of (11)- (14) based on the normal distribution are provided in the Appendix A. In addition, for interested readers, we also outline an approach based on general distributions in the Appendix B.
Employing a linear trend for tumor growth and the same death rate throughout the study, θ in the likelihood ratio test (19) 
. The following proposition is also immediate given the asymptotic normality of the maximum likelihood estimator under some regularity conditions (Silvey, 1970) . Since the expectation is difficult to calculate for Fisher's information matrix, we can use the observed Fisher information evaluated at the maximum likelihood estimate (Park et al. 2007 ; Efron and Hinkley, 1978) . We carried out the maximization of the likelihood function and the accompanying parameter estimations using an optimization function in R (optim, http://www.rproject.org). Optimization was carried out using the 'Nelder-Mead' algorithm and the likelihoods were calculated under 0 H and 1 H , respectively. Initial values of  ,  ,  and  were obtained by least square approach (e.g., the mixed effect model with the covariance structure of autoregression with order 1), based on the observed data (i.e., no consideration of the LOD or missing data).
Commonly, values of the -Log likelihood function around these initial values gradually decreasing toward an optimal point, thus the Nelder-Mead method provides a reasonable performance. The convergence is reasonably fast depending on a machine and the sample size (e.g., one optimization with 61 experimental units and 21 weeks takes approximately one minute using the IBM personal computer with Pentium D processor [3 GHz of CPU, 2.00 of RAM]). The program is available from the authors on request.
Simulation study
To investigate the performance of the proposed method, a simulation study was conducted. We use the characteristics of generated samples that are empirically close to those of the mammary tumor data from the Thoc1 gene deficiency study.
For our simulation studies, three treatment groups ( 3 K  ) were investigated. We first carried out 5000 Monte-Carlo simulations based on a "naïve" practice in which the repeated measures analysis was performed based on a linear model approach via a generalized least squares method. A first order autoregressive process was also assumed for the correlation structure. The likelihood function was evaluated based on the generalized linear model with and without the group factor to construct the likelihood ratio test. The interaction between time and group was considered in the model along with the group factor. In the simulations, we supposed that the data were log-transformed prior to the analysis. Note that in the real data set, N/A cases due to the LOD were simply recorded as 0. In a naïve manner, unavailable observations due to the LOD were replaced with log(0.00001). We used intercept and slope values around -6 and 0.45, respectively, to emulate the log-transformed tumor volume growth in the mammary tumor study. The number of visits was 21 (J=21) and the total sample size was 63 with three balanced treatment groups. Different values of  and  in equation (1) Table 2 show poor approximations to the 2  distribution. Among the examined cases, the Type I errors ranged from 0.0004 to 0.0870 and the 95 th percentiles ranged from 3.6480 to 11.6160, which indicate that the naïve test is not independent of the parameters. We also increased the sample size ( 90 N  ), but this did not improve the approximation (Table 2) . It is probably because the LOD problem is in effect (e.g., Perkins, 2007 Perkins, , 2009 ). This result clearly demonstrates that the naïve approach may not be appropriate for analyzing tumor growth data with unfavorable characteristics. The method proposed in this article could be used for these kinds of data sets.
We next examined the Type I error and power for the proposed method given the various scenarios. Similarly to the scenario described above, the simulations were carried out in order to emulate the mammary tumor development data. First, the values of log-transformed tumor volumes were generated based on the linear model with an intercept of -6 and a slope of 0.45 for all three treatment groups. The values of ij  were generated from Normal (0, 0.3
2 ), and  in (1) was given 0.9. There were a total of 21 observation times. The natural death rate was 0.01 per week. The values of L d and ik R d were -log (0.005) and 3, respectively. The death rate for each time was 0.01. The sample was equally allocated to all three treatment groups. Toward the end of the study, the survival rate was approximately 40% on average. The simulated Type I errors for these scenarios are shown in Table 3 . The survival rate in the table is the rate of mice alive at time J . The survival rate shows that data become scarce toward the end. The target Type I error is 0.05. The simulated Type I errors are somewhat greater than that when the sample size is small, but improve when the sample size increases. Table 3 also presents some other scenarios with different combinations of the sample size,  ,  and the number of visits. We also investigated the robustness of the model with constant death rate under the assumption of non-constant death rate. We generated data in which the death rates satisfied the model
. To be comparable to the entries in Tables 3 and 4 , we set up the overall mean death rate to be approximately equal to the constant death rate from Tables 3 and 4 (e.g., 
The proposed method demonstrated an overall robustness in terms of controlling Type I errors. For example, the Monte Carlo Type I error corresponding to the third entry in Table 3 ( 30 n  ) was 0.07 which is comparable to the Type I error for the correct model with a constant death rate in Table 3 , namely, 0.065. The powers with the same parameters and similar death rates to the second ( 30 n  ) and the fifth ( 63 n  ) entries in Table 4 were 0.08 and 0.35 indicating that the power is somewhat compromised. Note that the power of the proposed method is not compared with any other approach (e.g., Koziol et al., 1981; Tan et al., 2002) as such tests do not use a fully correct model specification.
To demonstrate a generalizability of our method, i.e., an extension toward the other distributions, we also carried out the simulations based on the tumor measurements only using the error terms with the Laplace distribution. The . The method to obtain the conditional densities is outlined in the Appendix B. Expectedly, the simulation results (based on 1000 simulations) showed a very good operating characteristic (Monte-Carlo Type I error = 0.050) even with a relatively small sample size ( 1 2 10 n n   ). Note that the likelihood function approach using the normal distribution showed a less accurate but viable performance (Monte-Carlo Type I error=0.055).
Applications
The Roswell Park data set includes observations for 21 weeks, from week 10 to week 30. A total of 63 mice were used (21, 24 , and 18 mice for the three groups). No tumor less than 0.01cm 3 was detected in the actual data set. At week 10, 89% of the data were below the LOD even though it is known that mammary hyperplasia can be detected as early as 4 weeks of age for the transgenic polyoma middle T (PyMT) mouse model. Toward the end of the study (week 30), 89% of mice were euthanized so that the data were markedly scarce. Table 5 shows the numbers of observations that are below the LOD and missing toward the end of the study. Note that none of the mice died naturally. Nevertheless, our proposed method and the data analysis strategy can easily be adapted to these. Tumor volumes are log-transformed before comparison. Histograms for the control group (Thoc1F/+MMTVCre+/-PyMT+/-) compared with the other two genotypes (Thoc1F/FPyMT+/-and Thoc1F/FMMTVCre+/-PyMT+/-) are shown in Figure 1 . In the early period (weeks 13 and 17), the control group shows markedly slower tumor development than the other two groups. Toward the end of the experiment, the differences are less distinct, as mice with large tumor volumes were euthanized. Throughout the study period, mice in the control group were euthanized less than the other two genotypes (Table 6 ). For example, 10% and 7% less mice were euthanized by week 21 and week 26, respectively. Considering all these facts, the control group seems to have a slower tumor growth overall. Figure 2 describes mean tumor volumes (the top plot) and the observation minus the sample mean tumor volumes at each time point (the bottom plot) using the log-transformed data. The top plot demonstrates the gradual growth of the tumors. Note that the plot may not correctly depict the tumor growth trend, as it was obtained by removing missing cases. Notice also that the mice with a high tumor volume died toward the end of the study so that the rate of growth of the mean tumor volume tends to be slower; however, the real tumor growth should be steeper than what is depicted in the plot. An increasing trend of the variance toward the end of the experiment is well-demonstrated in the bottom plot demonstrating that Model (1) and the corresponding covariance structure are reasonable. It also shows that some sizable losses of experimental units started around week 20 due to sacrifices, indicating that the simple sample variance of the tumor size can underestimate the actual variance of the tumor size. Overall, the linear trend looks reasonable for modeling the growth of tumor. The likelihood ratio test (19) We also performed the analysis for two additional longitudinal mouse experiments in order to demonstrate the applicability and performance of the proposed method across similar experiments. First, the data for the animal tumor immunotherapy experiment are taken from Koziol et al. (1981) . The data consist of three treatment groups of ten BALB/c mice (total of 30 mice) producing repeated measurements across 11 time points (from week 7 to week 21). Towards the end of the study, 37% of the total mice dropped out. When mice died, tumor sizes ranged from 320.1mm 3 to 937.5mm 3 . One mouse survived with a tumor size of 1014.0mm 3 . Note that Koziol et al. (1981) did not consider the probability of the natural death or LOD in their analysis as opposed to our approach. There was one case of an LOD observation. Since the study examines simple tumor growth, we assume a linear trend is appropriate (refer to Figure 1 Second, we examined our model using the data set from Tan et al. (2002) . In this dataset, they analyzed a set of log-transformed data from an experiment in which mice were allocated to three anti-cancer treatments in a randomized experiment. Twenty mice were randomly assigned to one of three treatments with 7, 7, and 6 mice. Tan et al. (2002) used a pair-wise comparison approach to investigate whether the differences in the drug dosages altered the antitumor activities manifested by the tumor volumes. Note that their approach does not provide a closed form for the test statistic. In the available data set, whether mice died due to natural cause or euthanasia is not specified. Since Tan et al. (2002) indicated that mice were sacrificed when their tumor grew to four times its initial volume, we considered mice deaths occurring before the threshold as natural. In the data set they provided (Tan et al., 2002) , we observed a total of 3 mice that died naturally and 1 mouse that was euthanized prior to the end of the experiment. Unlike the previous two examples, in this example, an antitumor regimen was employed to suppress tumor growth such that the tumor size actually reduced for a certain period and then re-grew (refer to Figure 1 in Tan et al., 2002) . Thus, a model with cubic polynomials was used adapting (20 ), strongly indicating a difference between treatments.
Concluding remarks
We have proposed an efficient method to carry out a group comparison for animal studies investigating longitudinal mammary tumor measurements. The proposed method employs a maximum likelihood methodology that accounts for the dependent data structure, the natural death rate, and the limit of detection. It is demonstrated that the proposed method allows us to carry out accurate inference (in terms of Type I error). The proposed method is sensitive in detecting differences between groups that are manifested by different death rates, even if no difference is shown in the observed tumor volumes. Our approach is easily implemented using R software packages for the various scenarios demonstrated in Section 4. 
